Generates over $120M in value, 700% ROAI™

创造了超过1.2亿美元的价值，投资回报率高达700% ROAI™

for in-flight initiatives, and over 250 use cases for multi-million-dollar healthcare organizations.

用于飞行中的计划，以及超过250个百万美元级医疗保健组织的用例。

NASHVILLE, Tenn.

田纳西州纳什维尔

,

，

May 14, 2026

2026年5月14日

/PRNewswire/ --

/PRNewswire/ --

Optura

奥普图拉

, the enterprise healthcare platform that delivers ROAI™ (Return on AI Investment), today announced a $17.5M Series A led by Salesforce Ventures, with participation from Echo Health Ventures and continued investment from Susa Ventures, Matrix Partners and HC9 Ventures, bringing total funding to over $25M to date.

，这家提供ROAI™（人工智能投资回报）的企业医疗平台，今天宣布完成了由Salesforce Ventures领投的1750万美元A轮融资，Echo Health Ventures参与投资，Susa Ventures、Matrix Partners和HC9 Ventures继续追加投资，截至目前总融资额已超过2500万美元。

The investment follows a momentum-driven seed round and validates what the market is already signaling: healthcare's AI moment has shifted from proof-of-concept to performance. Optura's platform is built for exactly that – to help organizations quickly assess AI business value and viability, prioritize AI investments and provide clear visibility into an AI's enterprise impact and return in real time..

这项投资是在一个由势头驱动的种子轮之后进行的，验证了市场已经在释放的信号：医疗保健的AI时刻已经从概念验证转向了性能表现。Optura的平台正是为此而建——帮助组织快速评估AI商业价值和可行性，优先考虑AI投资，并实时清晰地了解AI对企业影响和回报。

'The hundreds of AI use cases coupled with the introduction of foundational models into healthcare markets, like Claude for Healthcare, are driving AI spend and increasing risk,' said Andy Fanning, Co-Founder and CEO of Optura. 'It has also created a never-ending menu of point solutions, without an objective framework to help healthcare leaders measure the ROI on their AI investment decisions.

“数百个AI使用案例，再加上像Claude for Healthcare这样的基础模型引入医疗市场，正在推动AI支出并增加风险，”Optura的联合创始人兼首席执行官安迪·法宁表示。“这也造就了一个无休止的点解决方案菜单，缺乏一个客观的框架来帮助医疗领导者衡量其AI投资决策的ROI。”

We developed Optura to take out that guesswork and help healthcare organizations objectively measure results.'.

我们开发了Optura来消除这种猜测，并帮助医疗机构客观地衡量结果。

Rapid AI adoption exposes gap in the ability to measure value

快速的人工智能应用暴露了衡量价值能力的差距

Healthcare doesn't have an AI adoption problem. It has an AI results problem. The industry will spend over

医疗保健行业并不存在人工智能采纳问题，而是存在人工智能结果问题。该行业将花费超过

$18B on AI this year

今年在人工智能上投入180亿美元

, 46% of all healthcare investment. Yet, often the AI isn't a fit –

，占所有医疗投资的46%。然而，人工智能往往并不适用——

95%

95%

of enterprise GenAI pilots have produced no measurable value. As margins compress and economic headwinds intensify, the cost of chasing AI hype without accountability isn't just strategic risk; it's existential.

企业通用人工智能试点项目中，有 80% 没有产生可衡量的价值。随着利润空间缩小，经济逆风加剧，追逐人工智能热潮却无需承担责任的代价不仅仅是战略风险，更是关乎生存的问题。

'Healthcare organizations are under growing pressure to move beyond AI experimentation and deliver measurable business outcomes,' said Katie Thiry, Managing Director, Salesforce Ventures. 'Optura is helping customers bring greater rigor and visibility to AI investment decisions – identifying high-value use cases, measuring impact and accelerating time to ROI.

“医疗保健组织面临着越来越大的压力，需要超越人工智能实验阶段，并交付可衡量的业务成果，”Salesforce Ventures董事总经理凯蒂·塞里表示。“Optura正在帮助客户为人工智能投资决策带来更高的严谨性和可见性——识别高价值用例、衡量影响并加速实现投资回报率的时间。”

As enterprises look for more disciplined approaches to AI adoption, we believe Optura is well positioned to help lead that shift.'.

随着企业寻求更有条理的人工智能采用方法，我们相信Optura有能力帮助引领这一转变。

Since Optura's founding last year, the company has gained significant traction with enterprise health plans and providers, which include Independence Blue Cross, Prime Therapeutics, Ardent Health, among others. Today, more than $2B in AI initiatives are loaded into the platform, with $120M in tracked value at 700% ROAI™ on in-flight initiatives and over 250 new use cases identified.

自Optura去年成立以来，该公司在企业健康计划和提供商方面取得了显著的进展，其中包括Independence Blue Cross、Prime Therapeutics、Ardent Health等。目前，平台上已加载了超过20亿美元的人工智能项目，正在进行的项目中已跟踪到价值1.2亿美元、投资回报率（ROAI™）高达700%的成果，并已识别出250多个新的使用案例。

With the new funding, Optura will continue to invest in expanding AI capabilities, growing platform teams and scaling LLM partnerships..

通过这笔新的资金，Optura 将继续投资于扩展人工智能能力、壮大平台团队以及扩大大型语言模型合作伙伴关系。

'Optura is solving one of our industry's biggest challenges: helping healthcare organizations structure and capture real value from AI programs,' said Kurt Sheline, Partner, Echo Health Ventures. 'Its platform delivers the combination of data insights, tools and technology that we believe are consequential for moving into the next phase of AI transformation – accountability and orchestrated systems that deliver long-term value across the entire enterprise.'.

“Optura正在解决我们行业面临的最大挑战之一：帮助医疗机构构建并真正从人工智能项目中获取价值，”Echo Health Ventures的合伙人Kurt Sheline表示。“其平台提供了数据洞察、工具和技术的组合，我们认为这对进入人工智能转型的下一阶段至关重要——即实现责任明确且协调一致的系统，从而为企业整体带来长期价值。”

Optura helps healthcare organizations identify and prioritize AI use cases quickly and with minimal risk, taking a disciplined approach to measurement, evaluation and value creation. The ROAI™ platform:

Optura帮助医疗机构快速识别和优先考虑人工智能应用场景，同时将风险降至最低，并采取严谨的方法进行衡量、评估和价值创造。ROAI™ 平台：

Systematically maps an organization's existing data, regardless of fragmentation, into a unified knowledge layer so every decision is grounded in how that organization works.

系统地将组织现有的数据（无论其分散程度如何）映射到一个统一的知识层中，从而使每个决策都基于该组织的运作方式。

Scores and ranks use cases against organizational priorities, cost and readiness.

根据组织的优先事项、成本和准备情况对用例进行评分和排名。

Translates the top priorities into AI agents, trained specifically for healthcare and built directly from workflows and SOPs.

将最优先事项转化为专门针对医疗保健训练的AI代理，并直接根据工作流程和标准操作程序构建。

Simulates the expected return so organizations can determine the projected value before deployment.

模拟预期回报，以便组织可以在部署之前确定预计价值。

Deploys the AI agents across the enterprise, tracking outcomes, initiatives and projected value in one unified, real-time dashboard to provide clear visibility into AI impact.

在企业范围内部署人工智能代理，通过一个统一的实时仪表板跟踪结果、举措和预期价值，以清晰展示人工智能的影响。

'The question for health plans is no longer whether to invest in AI; it's whether those investments are actually delivering better outcomes for members,' said Michael R. Vennera, Executive Vice President and Chief Strategy, Technology and Operations Officer, Independence Blue Cross. 'Optura answers that question for an organization like IBX, where every decision connects back to the people we serve, that kind of accountability and visibility isn't optional; it's how we ensure AI creates real value where it matters most.'.

“对于健康计划而言，问题不再是是否投资于人工智能；而是这些投资是否真的为会员带来了更好的结果，” Independence Blue Cross执行副总裁兼首席战略、技术和运营官迈克尔·R. 维纳拉表示。“Optura回答了像IBX这样的组织所面临的问题，我们所做的每一个决策都与我们服务的人群息息相关，这种责任和透明度不是可选项；而是我们如何确保人工智能在最重要的地方创造真正价值的方式。”

To learn more about Optura, visit:

要了解有关 Optura 的更多信息，请访问：

https://optura.ai/

https://optura.ai/

About Optura

关于Optura

Optura is the enterprise healthcare platform for ROAI™ (Return on AI Investment). Industry-trained and organization-specific, Optura is the C-suite's secret advantage for deciding where AI dollars actually pay off. It translates leadership priorities into operational AI agents built directly from existing workflows and SOPs, simulates the returns before a dollar is committed and tracks live performance against the projection on a unified intelligence layer.

Optura 是面向 ROAI™（人工智能投资回报）的企业医疗平台。经过行业训练且针对组织特定需求，Optura 是高管团队的秘密优势，用于决定人工智能投资的实际回报点。它将领导层的优先事项转化为基于现有工作流程和标准操作程序（SOP）构建的运营型人工智能代理，在投入资金之前模拟回报，并通过统一的智能层实时跟踪与预测的绩效对比。

ROAI™ is the discipline that replaces directionless AI pilots with measurable performance, setting the modern standard for how healthcare leaders justify, fund and govern AI investment. More than $2B in healthcare AI initiatives run on Optura today, with $120M in tracked value at 700% ROAI™ on in-flight initiatives and over 250 new use cases identified.

ROAI™ 是一门学科，它用可衡量的性能取代了无方向的人工智能试点项目，为医疗保健领导者如何证明、资助和管理人工智能投资设定了现代标准。如今，Optura 上运行着超过 20 亿美元的医疗人工智能计划，在进行中的计划中已实现 700% 的 ROAI™，跟踪价值达 1.2 亿美元，并已确定超过 250 个新用例。

Optura is trusted by leading enterprise health plans and provider organizations..

Optura 受到领先的企业健康计划和供应商组织的信任。

Media Contact

媒体联系人

Andrea Heuer

安德烈亚·霍伊尔

917-914-5563

917-914-5563

[email protected]

电子邮件地址

SOURCE Optura

源 Optura

21

21

%

%

more press release views with

更多新闻发布视图与

Request a Demo

请求演示